US Stocks Open Lower; Nasdaq Slides Over 100 Points
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping more than 100 points on Tuesday.
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Dow Surges Over 100 Points; Crude Oil Rises Sharply
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
US Stocks Open Lower; Dow Falls Over 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Friday.
Financial Times Reported Earlier, Taiwan Semiconductor is in Advanced Talks With Key Suppliers About Setting Up Its First Potential European Plant in Dresden, Germany
https://www.ft.com/content/b006d898-0f46-460b-9abb-3281cdd097de
Dow Dips 600 Points; AMC Entertainment Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday.
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Dow Jumps Over 550 Points; Nike Earnings Beat Views
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 550 points on Wednesday.
AstraZeneca Announced Earlier Lynparza Approved in EU for Prostate Cancer; AstraZeneca to Receive $105M Milestone Payment from Merck
AstraZeneca and MSD's Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been approved in the European Union for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men for whom chemotherapy is not clinically indicated.